Financial News

Markets:

Overview

News

Currencies

International

Treasuries

Ikena Oncology, Inc. - Common Stock (NQ:IKNA)

1.430 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 25, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ikena Oncology, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Ikena Oncology Outlines Key Priorities and Provides Corporate Updates

January 18, 2024

From Ikena Oncology, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

December 15, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 24, 2023

Via Benzinga

Why Faraday Future Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket ↗

November 24, 2023

Shares of Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE) surged in pre-market trading after the company announced its foray into the Middle Ea

Via Benzinga

Ikena Oncology: Q3 Earnings Insights ↗

November 09, 2023

Via Benzinga

Analyst Ratings for Ikena Oncology ↗

May 16, 2023

Via Benzinga

Credit Suisse Maintains Outperform Rating for Ikena Oncology: Here's What You Need To Know ↗

March 15, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

November 17, 2023

Via Benzinga

Dow Falls Over 200 Points; Krispy Kreme Reports Downbeat Results ↗

November 09, 2023

U.S. stocks traded lower toward the end of trading, with the Dow Jones falling over 200 points on Thursday. The Dow traded down 0.71% to 33,871.77 while the NASDAQ fell 0.87% to 13,531.36. The S&P 500...

Via Benzinga

Topics Stocks

Why Is Cancer Firm Ikena Oncology Stock Trading Lower Today? ↗

November 09, 2023

Ikena Oncology Inc (NASDAQ: IKNA) shared initial data from twenty-six patients treated in the ongoing dose escalation portion of the

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

November 09, 2023

Via Benzinga

Crude Oil Rises Over 1%; Tapestry Posts Upbeat Earnings ↗

November 09, 2023

U.S. stocks traded slightly higher midway through trading, with the Nasdaq Composite gaining around 50 points on Thursday. The Dow traded up 0.01% to 34,114.64 while the NASDAQ rose 0.35% to 13,697.53....

Via Benzinga

Topics Stocks

Ikena Oncology Earnings Perspective: Return On Capital Employed ↗

March 15, 2023

Via Benzinga

Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

November 09, 2023

Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 83.5% to $0.4169 after reporting first-quarter results.

Via Benzinga

Ikena Oncology Shares Initial Positive and Differentiated Dose Escalation Data from IK-930 Phase I Trial and Reports Third Quarter 2023 Financial Results

November 09, 2023

From Ikena Oncology, Inc.

Via GlobeNewswire

Ikena Oncology to Present at Multiple November 2023 Investor Conferences

November 07, 2023

From Ikena Oncology, Inc.

Via GlobeNewswire

Optimism Surrounds Cancer Focused Ikena Oncology, Analyst Initiates With Outperform ↗

September 22, 2023

Ikena Oncology Inc (NASDAQ: IKNA) is garnering attention with its oncology-focused pipeline, and the company's recent developments have raised optimism in the medical community.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2023 ↗

September 22, 2023

Via Benzinga

Ikena Oncology to Participate in September 2023 Investor Conferences

September 05, 2023

From Ikena Oncology, Inc.

Via GlobeNewswire

Ikena Oncology Reports Second Quarter 2023 Financial Results and Corporate Update

August 10, 2023

From Ikena Oncology, Inc.

Via GlobeNewswire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

August 08, 2023

We're starting off the day with a look at all of the biggest pre-market stock movers worth keeping an eye on for Tuesday!

Via InvestorPlace

Ikena Oncology Acquires Pionyr Immunotherapeutics: Analysts See The Deal As Positive Move ↗

August 07, 2023

Ikena Oncology Inc (NASDAQ: IKNA) acquired Pionyr Immunotherapeutics Inc, a privately-held biotechnology company, in

Via Benzinga

Ikena Oncology Acquires Pionyr Immunotherapeutics in All-Stock Transaction

August 07, 2023

From Ikena Oncology, Inc.

Via GlobeNewswire

Ikena Oncology to Participate in Upcoming Investor Conferences

May 24, 2023

From Ikena Oncology, Inc.

Via GlobeNewswire

Ikena Oncology Reports First Quarter 2023 Financial Results and Highlights Advancements Across Targeted Oncology Pipeline

May 15, 2023

From Ikena Oncology, Inc.

Via GlobeNewswire

Ikena Oncology Announces $40 Million Underwritten Offering

May 15, 2023

From Ikena Oncology, Inc.

Via GlobeNewswire

Ikena Oncology to Participate in the Stifel 2023 Virtual Targeted Oncology Days

April 20, 2023

From Ikena Oncology, Inc.

Via GlobeNewswire

Ikena Oncology Shares Differentiation Profile of IK-930, a Novel Hippo-Pathway Inhibitor, Including Projected Therapeutic Index Advantages and Breadth of Patient Populations at AACR 2023 Annual Meeting

April 17, 2023

From Ikena Oncology, Inc.

Via GlobeNewswire

Ikena Oncology Reports Fourth Quarter and Full Year 2022 Financial Results

March 14, 2023

From Ikena Oncology, Inc.

Via GlobeNewswire

Ikena Oncology Presents Preclinical Data on IK-595, Best-in-Class Next-Generation MEK-RAF Complex Inhibitor, in Plenary Session at AACR Special Conference on RAS Targeting

March 07, 2023

From Ikena Oncology, Inc.

Via GlobeNewswire

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Financial News

Ikena Oncology, Inc. - Common Stock (NQ:IKNA)

All News about Ikena Oncology, Inc. - Common Stock

Popular Pages